Cognitive function improvement effect by FJ-319 compounded food

Cognitive function improvement effect by FJ-319 compounded food : a randomized, double-blind, placebo-controlled, cross-over trial. - Cognitive function improvement effect by FJ-319 compounded food

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042623

Enrollment

Registered

2020-12-03

Start date

2020-12-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

first trial

Intake test article second trial

Intake placebo first trial

Intake placebo second trial

Intake test article

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who do not have dementia but are aware of age-related decline in cognitive function

Exclusion criteria

Exclusion criteria: 1. Subjects who are judged to have dementia, those who are receiving treatment, medication, and lifestyle guidance from a doctor due to dementia, those who have received it in the past 2. Subjects with serious cerebrovascular disease, heart disease, liver disease, kidney disease, digestive system disease, infectious diseases that require notification, etc.

Design outcomes

Primary

Measure	Time frame
WMS-R	—

Secondary

Measure	Time frame
TMT-J, LFT	—

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan clinical trial assosiation N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026